BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28098895)

  • 1. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
    Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAp63 suppress metastasis via miR-133b in colon cancer cells.
    Lin CW; Li XR; Zhang Y; Hu G; Guo YH; Zhou JY; Du J; Lv L; Gao K; Zhang Y; Deng H
    Br J Cancer; 2014 Apr; 110(9):2310-20. PubMed ID: 24594999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
    Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
    Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
    Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
    Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression.
    Dai J; Wu H; Zhang Y; Gao K; Hu G; Guo Y; Lin C; Li X
    Oncotarget; 2016 Dec; 7(52):87147-87160. PubMed ID: 27894087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
    Wang L; Jiang CF; Li DM; Ge X; Shi ZM; Li CY; Liu X; Yin Y; Zhen L; Liu LZ; Jiang BH
    Oncotarget; 2016 Jan; 7(3):2660-71. PubMed ID: 26673620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
    Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
    Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
    J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
    Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.
    Zhou J; Lv L; Lin C; Hu G; Guo Y; Wu M; Tian B; Li X
    Mol Med Rep; 2015 Oct; 12(4):5407-14. PubMed ID: 26151111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.